Clinical trial
A Randomized Double-blind Trial to Explore Effectiveness of Stellate Ganglion Block in Individuals With Parkinson's Disease
NCT06301724 is registered in ClinicalTrials.gov with Muhammad as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double-blind Trial to Explore Effectiveness of Stellate Ganglion Block in Individuals With Parkinson's Disease
- Lead sponsor
- Muhammad
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2024
- Completion date
- June 30, 2024
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.